{"id":"https://openalex.org/W2731908664","doi":"https://doi.org/10.1016/j.bbi.2017.06.014","title":"The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman\u2019s disease","display_name":"The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman\u2019s disease","alternate_titles":[],"publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2731908664","doi":"https://doi.org/10.1016/j.bbi.2017.06.014","mag":"2731908664","pmid":"https://pubmed.ncbi.nlm.nih.gov/28676350"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbi.2017.06.014","doi":"https://doi.org/10.1016/j.bbi.2017.06.014","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bbi.2017.06.014","pdf_url":null,"source":{"id":"https://openalex.org/S102243518","display_name":"Brain Behavior and Immunity","issn_l":"0889-1591","issn":["0889-1591","1090-2139"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain, Behavior, and Immunity","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2731908664"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101504329","display_name":"Yu Sun","orcid":"https://orcid.org/0000-0002-2056-7624","observed_orcids":["https://orcid.org/0000-0002-2056-7624"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Sun","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101574289","display_name":"Dai Wang","orcid":"https://orcid.org/0000-0002-4936-3713","observed_orcids":["https://orcid.org/0000-0002-4936-3713"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dai Wang","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053776875","display_name":"Giacomo Salvadore","orcid":"https://orcid.org/0009-0001-0212-4643","observed_orcids":["https://orcid.org/0009-0001-0212-4643"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giacomo Salvadore","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051127450","display_name":"Benjamin L. Hsu","orcid":"https://orcid.org/0000-0002-0718-213X","observed_orcids":["https://orcid.org/0000-0002-0718-213X"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Hsu","raw_affiliation_strings":["Immunology Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107600575","display_name":"Mark E. Curran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Curran","raw_affiliation_strings":["Immunology Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085370688","display_name":"Corey Casper","orcid":"https://orcid.org/0000-0002-3609-661X","observed_orcids":["https://orcid.org/0000-0002-3609-661X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Casper","raw_affiliation_strings":["Fred Hutchison Cancer Research Center, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchison Cancer Research Center, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053469869","display_name":"JESSICA T. VERMEULEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Vermeulen","raw_affiliation_strings":["Oncology Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111744250","display_name":"JUSTINE M. KENT","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justine M. Kent","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023527028","display_name":"Jaskaran B. Singh","orcid":"https://orcid.org/0000-0001-8466-0994","observed_orcids":["https://orcid.org/0000-0001-8466-0994"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaskaran Singh","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029257842","display_name":"Wayne Curtis Drevets","orcid":"https://orcid.org/0000-0002-5097-3930","observed_orcids":["https://orcid.org/0000-0002-5097-3930"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne C. Drevets","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046111155","display_name":"Gayle M. Wittenberg","orcid":"https://orcid.org/0009-0004-4299-5138","observed_orcids":["https://orcid.org/0009-0004-4299-5138"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gayle M. Wittenberg","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100323038","display_name":"Guang Chen","orcid":"https://orcid.org/0000-0002-9209-5494","observed_orcids":["https://orcid.org/0000-0002-9209-5494"]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]},{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Guang Chen","raw_affiliation_strings":["Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States. Electronic address: GChen13@its.jnj.com","Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States. Electronic address: GChen13@its.jnj.com","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]},{"raw_affiliation_string":"Neuroscience Therapeutic Areas, Janssen Research & Development, LLC, Janssen Pharmaceutical Companies of Johnson & Johnson, United States","institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5100323038"],"corresponding_institution_ids":["https://openalex.org/I1330063522","https://openalex.org/I4210151386","https://openalex.org/I4405282460"],"apc_list":{"value":5680,"currency":"USD","value_usd":5680},"apc_paid":null,"fwci":6.6323,"has_fulltext":false,"cited_by_count":107,"citation_normalized_percentile":{"value":0.97726508,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"66","issue":null,"first_page":"156","last_page":"164"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.49880000948905945,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.49880000948905945,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.4603999853134155,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9800000190734863},{"id":"https://openalex.org/keywords/il-6-neutralizing-antibody","display_name":"IL-6 neutralizing antibody","score":0.9089999794960022},{"id":"https://openalex.org/keywords/sirukumab","display_name":"sirukumab","score":0.9599999785423279},{"id":"https://openalex.org/keywords/siltuximab","display_name":"siltuximab","score":1.0},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/multicentric-castleman-disease","display_name":"multicentric Castleman disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/depressive-symptoms","display_name":"depressive symptoms","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anhedonia","display_name":"anhedonia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.7480000257492065},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.6710000038146973},{"id":"https://openalex.org/keywords/soluble-il-6-receptor","display_name":"soluble IL-6 receptor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/nonresponders","display_name":"non-responders","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2778941446","wikidata":"https://www.wikidata.org/wiki/Q545365","display_name":"Anhedonia","level":3,"score":0.8922381401062012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7021709680557251},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6810012459754944},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.6510028839111328},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6247360706329346},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6121219396591187},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.41831257939338684},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3808295726776123},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3640729486942291},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3404652774333954},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08176422119140625},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005871","descriptor_name":"Castleman Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D005871","descriptor_name":"Castleman Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059445","descriptor_name":"Anhedonia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bbi.2017.06.014","doi":"https://doi.org/10.1016/j.bbi.2017.06.014","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bbi.2017.06.014","pdf_url":null,"source":{"id":"https://openalex.org/S102243518","display_name":"Brain Behavior and Immunity","issn_l":"0889-1591","issn":["0889-1591","1090-2139"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain, Behavior, and Immunity","raw_type":"journal-article"},{"id":"pmid:28676350","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28676350","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain, behavior, and immunity","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337415","display_name":"Janssen Research and Development","ror":"https://ror.org/03qd7mz70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W1509868652","https://openalex.org/W1848493697","https://openalex.org/W1964160392","https://openalex.org/W1974390576","https://openalex.org/W1975588273","https://openalex.org/W1977593923","https://openalex.org/W1981654563","https://openalex.org/W1985438873","https://openalex.org/W1988422061","https://openalex.org/W1989580462","https://openalex.org/W1993856151","https://openalex.org/W1995596015","https://openalex.org/W1997237519","https://openalex.org/W2003185913","https://openalex.org/W2006228075","https://openalex.org/W2007121025","https://openalex.org/W2009878480","https://openalex.org/W2013586266","https://openalex.org/W2016883790","https://openalex.org/W2017687858","https://openalex.org/W2018416312","https://openalex.org/W2018529141","https://openalex.org/W2023299675","https://openalex.org/W2025256335","https://openalex.org/W2030593831","https://openalex.org/W2044404835","https://openalex.org/W2046497466","https://openalex.org/W2047570180","https://openalex.org/W2061809825","https://openalex.org/W2064412851","https://openalex.org/W2071161538","https://openalex.org/W2073791328","https://openalex.org/W2079562810","https://openalex.org/W2089521828","https://openalex.org/W2091259554","https://openalex.org/W2094747247","https://openalex.org/W2097147259","https://openalex.org/W2101529881","https://openalex.org/W2109668208","https://openalex.org/W2111038577","https://openalex.org/W2111649281","https://openalex.org/W2112725884","https://openalex.org/W2115679410","https://openalex.org/W2117615657","https://openalex.org/W2118778038","https://openalex.org/W2128952811","https://openalex.org/W2136812855","https://openalex.org/W2139253645","https://openalex.org/W2156150528","https://openalex.org/W2164860485","https://openalex.org/W2166667138","https://openalex.org/W2168911501","https://openalex.org/W2169031812","https://openalex.org/W2236616974","https://openalex.org/W2399060753","https://openalex.org/W2464733045","https://openalex.org/W2511596774","https://openalex.org/W2519882707","https://openalex.org/W2525291061","https://openalex.org/W2575088345","https://openalex.org/W2585572290","https://openalex.org/W2625857951"],"related_works":["https://openalex.org/W2755751238","https://openalex.org/W2610056779","https://openalex.org/W2414800681","https://openalex.org/W2893606592","https://openalex.org/W2507577540","https://openalex.org/W2921569358","https://openalex.org/W4399546463","https://openalex.org/W4411066751","https://openalex.org/W2884023399","https://openalex.org/W3049395663"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2731908664","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-07-14T00:00:00"}
